share_log

信達生物：截至2024年1月31日止月份之股份發行人的證券變動月報表

INNOVENT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 6 05:11
Summary by Moomoo AI
信達生物製藥於2024年1月31日的股份變動月報表顯示，公司普通股股份數目維持在5,000,000,000股，法定/註冊股本總額為50,000美元。同期，已發行股份有所增加，從1,621,830,905股增至1,622,582,897股，增加了751,992股。該增加主要來自於股份期權的行使，其中包括首次公開發售前股份獎勵計劃和首次公開發售後僱員持股計劃，導致股份期權計劃下的股份數目減少。本月內因行使期權所得資金總額為4,560,190.75港元。報告由聯席公司秘書王豔菊於2024年2月6日呈交給香港交易及結算所有限公司。
信達生物製藥於2024年1月31日的股份變動月報表顯示，公司普通股股份數目維持在5,000,000,000股，法定/註冊股本總額為50,000美元。同期，已發行股份有所增加，從1,621,830,905股增至1,622,582,897股，增加了751,992股。該增加主要來自於股份期權的行使，其中包括首次公開發售前股份獎勵計劃和首次公開發售後僱員持股計劃，導致股份期權計劃下的股份數目減少。本月內因行使期權所得資金總額為4,560,190.75港元。報告由聯席公司秘書王豔菊於2024年2月6日呈交給香港交易及結算所有限公司。
Sindh Biopharmaceuticals reported on January 31, 2024, that the number of ordinary shares of the company remained at 5,000,000,000 shares, with a total regulated/registered share capital of $50,000. In the same period, issued shares increased from 1,621,830,905 shares to 1,622,582,897 shares, an increase of 751,992 shares. The increase resulted primarily from the exercise of stock options, which include the pre-IPO share bonus program and the employee stock holding plan after the initial public offering, resulting in a reduction in the number of shares under the stock option program. The total amount of capital gained from the exercise of options during the month was HK$4,560,190.75. The report was presented to Hong Kong Trading and Settlement Limited by the Joint Secretary of the Joint Undertaking, Mr Wang, on 6 February 2024.
Sindh Biopharmaceuticals reported on January 31, 2024, that the number of ordinary shares of the company remained at 5,000,000,000 shares, with a total regulated/registered share capital of $50,000. In the same period, issued shares increased from 1,621,830,905 shares to 1,622,582,897 shares, an increase of 751,992 shares. The increase resulted primarily from the exercise of stock options, which include the pre-IPO share bonus program and the employee stock holding plan after the initial public offering, resulting in a reduction in the number of shares under the stock option program. The total amount of capital gained from the exercise of options during the month was HK$4,560,190.75. The report was presented to Hong Kong Trading and Settlement Limited by the Joint Secretary of the Joint Undertaking, Mr Wang, on 6 February 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more